Delirium after gabapentin withdrawal. Case report

Canadian Journal of Neurological Sciences

Volumn 40, Issue 1, 2013, Pages 126-127

  Di Fabio, Roberto ^a   D'Agostino, Cecilia ^a   Baldi, Giulio ^a   Pierelli, Francesco ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; HALOPERIDOL;

AGED; CASE REPORT; COORDINATION DISORDER; DELIRIUM; DIZZINESS; DROWSINESS; DRUG MECHANISM; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTRONEUROGRAPHY; FEMALE; FOCAL EPILEPSY; HUMAN; LETTER; LOW DRUG DOSE; MEDICAL HISTORY; MENTAL DISEASE; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSORY NEUROPATHY; SPEECH DISORDER; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

AGED; AMINES; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; DELIRIUM; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROLOGIC EXAMINATION;

EID: 84871293297     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Mack A. Examination of the evidence for off-label use of gabapentin. J Manag Care Pharm. 2003;9(6):559-68
2. norton JW. Gabapentin withdrawal syndrome. Clin neuropharmacol. 2001;24(4):245-6
3. Hellwig TR, Hammerquist R, Termaat J. Withdrawal symptoms after gabapentin discontinuation. Am J Health Syst Pharm. 2010; 67(11):910-2
4. Gee nS, Brown JP, Dissanayake VUK, Offord J, Thurlow R, Woodruff Gn. The novel anticonvulsant drug, gabapentin (neurontin), binds to the a2d subunit of a calcium channel. J Biol Chem. 1996;271(10):5768-76
5. Uchitel OD, Di Guilmi Mn, Urbano FJ, Gonzalez-Inchauspe C. Acute modulation of calcium currents and synaptic transmission by gabapentinoids. Channels (Austin). 2010;4(6):490-6